Abstract
For the past few years in the neurologic service at Bellevue Hospital, under the direction of Dr. Foster Kennedy, we have been studying the etiology and treatment of migraine. Realizing that this affliction is not a disease entity and that there is more than one precipitating factor in the production of this syndrome, we felt it essential to investigate this paradox from many different angles. In a report in 1934 we1approached the problem from a pharmacologic point of view. At that time we administered known vasodilator and vasoconstrictor agents, also glandular products such as pitressin, extract of anterior pituitary, theelin and insulin. We also studied the effects of carbon dioxide inhalation, of vagomimetic and of sympathomimetic compounds on the attacks. These various medications were used in order to compare the relative effectiveness of numerous nonsedative measures in relieving the episode, as well as to determine the factors capable
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
